Coherus Oncology, Inc.
CHRS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $103 | $217 | $82 | $126 |
| Short-Term Investments | $88 | $21 | $0 | $0 |
| Receivables | $250 | $120 | $62 | $122 |
| Inventory | $2 | $5 | $4 | $70 |
| Other Curr. Assets | $17 | $18 | $162 | $23 |
| Total Curr. Assets | $461 | $380 | $310 | $342 |
| Property Plant & Equip (Net) | $2 | $2 | $2 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $49 | $52 | $53 | $54 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $4 | $5 | $6 | $50 |
| Total NC Assets | $56 | $59 | $61 | $107 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $517 | $439 | $371 | $449 |
| Liabilities | – | – | – | – |
| Payables | $25 | $38 | $41 | $28 |
| Short-Term Debt | $2 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $347 | $226 | $212 | $253 |
| Total Curr. Liab. | $374 | $265 | $255 | $283 |
| LT Debt | $39 | $39 | $268 | $268 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $1 | $1 | $1 | $1 |
| Other NC Liab. | $15 | $14 | $30 | $28 |
| Total NC Liab. | $55 | $55 | $299 | $298 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $4 | $5 | $5 |
| Total Liabilities | $429 | $320 | $555 | $581 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,345 | -$1,310 | -$1,608 | -$1,551 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $1,433 | $1,430 | $1,424 | $1,419 |
| Total Equity | $88 | $120 | -$183 | -$132 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $517 | $439 | $371 | $449 |
| Net Debt | -$63 | -$176 | $188 | $144 |